Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Circulating platelet aggregates in glaucoma.

L Bojić1, L Skare-Librenjak

  • 1Department of Ophthalmology, Clinical Hospital Split, Croatia.

International Ophthalmology
|November 5, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Observational study of patients switched to the fixed travoprost 0.004%/timolol 0.5% combination in Croatia.

Methods and findings in experimental and clinical pharmacology·2010
Same author

Role of haematological testing: ratio values of circulating platelet aggregates in visual field loss associated with pseudoexfoliation glaucoma.

Bratislavske lekarske listy·2010
Same author

Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice.

Oncogene·2008
Same author

The spectrum of diffuse and focal liver lesions in workers exposed to vinylchloridemonomer.

Annals of Saudi medicine·2007
Same author

Should we screen for asymptomatic left ventricular dysfunction in glaucoma patients?

Annals of Saudi medicine·2007
Same author

Visco and phacoviscocanalostomy in managing glaucoma patients.

Collegium antropologicum·2003
Same journal

Clinical characteristics, management, and visual outcomes of presumed infectious and non-infectious anterior scleritis in a tuberculosis-endemic Indonesian Tertiary Center.

International ophthalmology·2026
Same journal

Assesment of oxidative stress and antioxidant status in pseudoexfoliation syndrome with ocular and systemic comorbidities.

International ophthalmology·2026
Same journal

Surgical outcomes of 27-gauge sutureless versus 23-gauge sutured techniques in congenital cataract surgery: a comparative study.

International ophthalmology·2026
Same journal

Myopia management functional lenses (MMFL): a bibliometric analysis of multidisciplinary perspective and trend insights in the context of vision health.

International ophthalmology·2026
Same journal

Levels of DEL-1 and IL-17 in the aqueous humor of cataract patients with diabetes without diabetic retinopathy.

International ophthalmology·2026
Same journal

Improvement of pattern electroretinogram parameters following glaucoma surgery.

International ophthalmology·2026
See all related articles

Circulating platelet aggregates (CPA) were elevated in advanced glaucoma patients compared to healthy individuals. Measuring CPA may help assess atherothrombotic events in glaucoma.

Area of Science:

  • Ophthalmology
  • Hematology
  • Cardiovascular Research

Background:

  • Glaucoma is a leading cause of irreversible blindness worldwide.
  • Atherothrombotic events are increasingly recognized as potential contributors to glaucoma pathogenesis.

Purpose of the Study:

  • To investigate the association between circulating platelet aggregates (CPA) and advanced open-angle glaucoma.
  • To explore CPA as a potential biomarker in glaucoma.

Main Methods:

  • Circulating platelet aggregates (CPA) were quantified in vivo.
  • Study included 32 patients with advanced open-angle glaucoma and visual field loss.
  • A control group of 20 healthy volunteers was included for comparison.

Main Results:

Related Experiment Videos

  • Glaucoma patients exhibited a significantly higher platelet aggregate ratio compared to healthy controls (p = 0.002).
  • Elevated CPA levels suggest increased platelet activation in advanced glaucoma.

Conclusions:

  • The measurement of platelet aggregate ratio may serve as an exploratory tool.
  • This assessment could help elucidate the role of atherothrombotic events in the development and progression of glaucoma.